๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I Controlled trials of WR-2721 and cyclophosphamide

โœ Scribed by John H. Glick; Donna Glover; Clare Weiler; Lorraine Norfleet; John Yuhas; Morton M. Kligerman

Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
506 KB
Volume
10
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I trials of WR-2721 and cis-platin
Phase I trials of WR-2721 and cis-platinum
โœ Donna Glover; John H. Glick; Clare Weiler; John Yuhas; Morton M. Kligerman ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 477 KB
Phase I/II trials of WR-2721 and cis-pla
Phase I/II trials of WR-2721 and cis-platinum
โœ Donna Glover; John H. Glick; Clare Weiler; Kevin Fox; Andrew Turrisi; Morton M. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 528 KB
Topical application of WR-2721 to preven
Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial
โœ Gusfavo S. Montana; Mitchell S. Anscher; Charles M. Mansbach II; Nicolas Duly; M ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 439 KB

Patients undergoing x-ray therapy to the pelvis have intestinal symptoms proportional to the volume treated and the dose delivered. WR-2721, S-2 (3-aminopropylaminoethyl) phosphorothioic acid, is an organic thiophosphate compound that selectively protects normal tissues against radiation effects. A